Agenda
- Challenging Cases in HIV Care
- Beyond ART: The Role of the HIV Provider in the Care of PLWH
- Question and Answer Session
Events
Date / Time
Event Details
Faculty
Faculty
David Hardy, MD
Adjunct Professor of Medicine
Division of Infectious Diseases
Johns Hopkins University School of Medicine
Washington, DC
Faculty
sally Hodder, MD
Director, Clinical Translation Science Institute
Associate Vice President, Clinical and Translational Research
Professor of Medicine
West Virginia University
Morgantown, West Virginia
Faculty
Princy Kumar, MD
Professor of Medicine and Microbiology
Chief, Division of Infectious Diseases and Travel Medicine
Senior Associate Dean of Students
Georgetown University School of Medicine
Washington, DC
Faculty
Babafemi Taiwo, MBBS
Gene Stollerman Professor of Medicine
Chief, Division of Infectious Diseases
Northwestern University Feinberg School of Medicine
Chicago, Illinois
Program Overview
The primary purpose of this program is to arm clinicians with tools to address the most important and most current challenges in HIV management by providing a tightly focused update on recent advances and key clinical issues encountered in the clinic.
Goal Statement
The goal of this activity is to improve participants’ competence in addressing the most important and most current challenges in HIV management by providing a tightly focused update on recent advances and key clinical issues encountered in the clinic.
Target Audience
This program is intended for HIV specialists, infectious diseases clinicians, registered nurses, pharmacists, and other healthcare professionals involved in the care of patients with HIV infection.
Learning Objectives
At the conclusion of this activity, participants should be able to:
- Apply the results of recent clinical studies and evolving treatment guidelines on the timing and choice of first-line ART and switch strategies, and managing treatment-experienced HIV-infected patients
- Effectively prevent or manage drug–drug interactions, adverse events, and other complications associated with HIV, ART, and comorbidities
- Apply evidence-based strategies for the use of ART as prevention
Accreditation
Physician Continuing Medical Education
Accreditation Statement
The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation
The Annenberg Center for Health Sciences at Eisenhower designates this live activity for a maximum of 2.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Education
Accreditation Statement
Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Credit Designation
2.5 contact hours may be earned for successful completion of this activity.
Pharmacist Continuing Education
Accreditation Statement
The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Credit Designation
This program has been assigned ACPE Universal Activity #0797-9999-19-046-L02-P. This program is designated for up to 2.5 contact hours (0.25 CEUs) of continuing pharmacy education credit.
Type of Activity: Application
For Pharmacists: Upon receipt of the completed activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 4 weeks.
Disclosure of Conflicts of Interest
The Annenberg Center for Health Sciences at Eisenhower requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to the Annenberg Center for Health Sciences at Eisenhower policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.